Renovaro Inc. 8-K: Name History and Corporate Details Update
Ticker: LNAI · Form: 8-K · Filed: Feb 16, 2024 · CIK: 1527728
| Field | Detail |
|---|---|
| Company | Renovaro Inc. (LNAI) |
| Form Type | 8-K |
| Filed Date | Feb 16, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $3,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-update, name-change, administrative
TL;DR
**Renovaro Inc. filed an 8-K updating its corporate name history and contact info, nothing major.**
AI Summary
Renovaro Inc. filed an 8-K on February 16, 2024, under the 'Other Events' item. The filing indicates a change in the company's name history, with previous names including Renovaro Biosciences Inc. and Enochian Biosciences Inc., with the most recent name change to Renovaro Inc. occurring on August 7, 2023. The company's business address is 2080 Century Park East, Suite 906, Los Angeles, CA 90067, and its CIK is 0001527728.
Why It Matters
This filing provides updated corporate information, including name changes and contact details, which is crucial for investors to maintain accurate records and understand the company's current identity.
Risk Assessment
Risk Level: low — The filing is purely administrative, updating corporate details and name history, with no material financial or operational changes.
Key Players & Entities
- RENOVARO INC. (company) — Registrant
- Renovaro Biosciences Inc. (company) — Former company name
- Enochian Biosciences Inc. (company) — Former company name
- February 16, 2024 (date) — Date of earliest event reported
- August 7, 2023 (date) — Date of name change to Renovaro Inc.
- 0001527728 (company) — Central Index Key (CIK)
- 2080 Century Park East, Suite 906, Los Angeles, CA 90067 (company) — Business address
FAQ
What is the current name of the registrant?
The current name of the registrant is RENOVARO INC.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on February 16, 2024.
What was one of the former names of Renovaro Inc.?
One of the former names of Renovaro Inc. was Renovaro Biosciences Inc.
What is the Central Index Key (CIK) for Renovaro Inc.?
The Central Index Key (CIK) for Renovaro Inc. is 0001527728.
What is the business address of Renovaro Inc.?
The business address of Renovaro Inc. is 2080 Century Park East, Suite 906, Los Angeles, CA 90067.
Filing Stats: 447 words · 2 min read · ~1 pages · Grade level 11.3 · Accepted 2024-02-16 08:35:25
Key Financial Figures
- $0.0001 — ch Registered Common Stock, par value $0.0001 per share RENB The Nasdaq Stock Mar
- $3,000,000 — ed commitments for additional equity of $3,000,000, all of which are expected to close on
Filing Documents
- e5430_8-k.htm (8-K) — 25KB
- 0001731122-24-000257.txt ( ) — 194KB
- renb-20240216.xsd (EX-101.SCH) — 3KB
- renb-20240216_lab.xml (EX-101.LAB) — 33KB
- renb-20240216_pre.xml (EX-101.PRE) — 22KB
- e5430_8-k_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On February 16, 2024, Renovaro Inc. (the " Company ") announced that it has received commitments for additional equity of $3,000,000, all of which are expected to close on Tuesday, February 20, 2024. The information included in this Item 8.01 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that Section or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RENOVARO INC. By: /s/ Mark Dybul, M.D. Name: Mark Dybul Title: Chief Executive Officer Date: February 16, 2024